AUTHORS
CASE/OPPOSITION DECISIONS
Crystalline Adefovir Dipivoxil PreGrant
Roche et al v. Cipla (Tarceva II)
Pegasys PostGrant
Oseltamivir (Tamiflu) PreGrant
Roche v. Cipla (Tarceva I)
Caduet PreGrant
Erlotinib (Tarceva) PreGrant
Valganciclovir (Valcyte) PreGrant
INP et al v. UOI et al (Valganciclovir)
Bayer v. Cipla (Sorafenib)
Previous Posts
Back from vacation
Vote for the Top Patent Law Blogs
Indian Patent Office Categorized Examiners and Con...
More Problems for Tarceva
Wyeth-Lupin Settles Effexor ER Patent Dispute
Chantix Patent in Post Grant Proceeding
Cipla Took the Delhi High Court for a Ride
PreGrant Opposition: Erlotinib Polymorph B Rejecte...
PreGrant Opposition: Erlotinib Polymorph B Rejecte...
PreGrant Opposition: Crystalline Adefovir Dipivoxi...
Archives
patent blogs
Patent Baristas by Stephen
Patent Docs by Donald Zuhn et al.
Orangebook Blog by Aaron Barkoff
Patently-O by Dennis Crouch
IPKat by Jeremy Phillips et al.
IP Thinktank Blog by Duncan
IP Thoughts by Rand Bateman
Patent Prospector by Gary Odom
The Prior Art by Joe Mullin
Anticipate This! by Jacob Ward et al.
Patent Pending Blog by Bob Shaver
Patentably Defined by Michael
I/P Updates by William Heinze
Promote the Progress by J. Matthew
271 Patent Blog by Peter Zura
IAM Blog by Joff Wild
IP Doctor by Dr. Yosef Freedland
SpicyIP by Shamnad et al
Phosita by Sorocco et al.
Disclaimer
“Patent Circle” does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create any business relationship. “Patent Circle” is the personal weblog of the Authors; not edited by the Author’s employers or clients and, as such, no part of this weblog may be so attributed. “Patent Circle” will always strive to be unbiased in its reporting. Though posts on “Patent Circle” are thoroughly scrutinized before posting but should be double-checked for their accuracy and current applicability.
Copyright © Patent Circle 2009.
Copyright © Patent Circle 2009.
Subscribe to
Posts [Atom]
